Business
NATIONAL VISION HOLDINGS, INC. (EYE) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against National Vision Holdings, Inc. (EYE)
Did you lose money on investments in National Vision Holdings? If so, please visit  National...
About this update from Rise Nano Optics Ltd.
[{"type":"text","content":"NATIONAL VISION HOLDINGS, INC. (EYE) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion In a Securities Class Action Lawsuit Against National Vision Holdings, Inc. (EYE)Did you lose money on investments in National Vision Holdings? If so, please visit National Vision Holdings, Inc. Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights. New York, New York--(Newsfile Corp. - February 23, 2023) - Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the common stock of National Vision Holdings, Inc. (\"National Vision\" or the \"Company\") (NASDAQ: EYE) between May 13, 2021 and May 9, 2022, inclusive (the \"Class Period\"). The lawsuit was filed in the United States District Court for the Northern District of Georgia and alleges violations of the Securities Exchange Act of 1934. National Vision is an optical retailer that provides eye exams, eyeglasses, and contact lenses to value-seeking and lower-income consumers.Plaintiff alleges that Defendants made materially false and misleading statements throughout the Class Period. Specifically, Plaintiff alleges that Defendants failed to disclose that: (i) National Vision was experiencing extraordinary wage and labor pressures as a result of intense competition and disruptions in the labor market due to the COVID-19 pandemic; (ii) National Vision had made a significant multi-million dollar investment in wage and compensation payments to its vision care professionals to prevent mass defections in the middle of 2021; (iii) the enhanced payouts were expected to negatively impact National Vision's fourth quarter 2021 costs and profit margins to an extent materially greater than what had been disclosed to investors; (iv) as a result, National Vision's profitability metrics were expected to deteriorate below not only favorable 2020 results, but also below pre-pandemic levels; and (v) consequently, there was a substantial undisclosed risk that National Vision would experience staff and optometrist shortages and capacity constraints. On May 10, 2022, National Vision ...